Clik here to view.
Novocure touts long-term analysis of Optune drug-device combo
Novocure (NSDQ: NVCR) touted a long-term analysis of data from a Phase III pivotal trial of its Optune device in combination with temozolomide for the treatment of newly-formed glioblastomas. Survival...
View ArticleClik here to view.
Chemists develop 3D bone-scanning technique
Chemists at Trinity College Dublin created a 3D bone-scanning technique that does not expose patients to radiation. The team attached a luminescent tag to tiny, gold structures called nanoagents. The...
View ArticleClik here to view.
Nordisk issues voluntary recall of GlucaGen HypoKits
Novo Nordisk (NYSE:NVO) issued a voluntary recall of 6 batches of its GlucaGen HypoKits in the U.S., after reports of detached needles in the syringes. The company initiated the recall following 2...
View ArticleClik here to view.
Coapt looks to bring prosthetic electrodes into the 21st century
When Jodie O’Connell-Ponkos was 16, she lost her right arm in a meat-grinding accident.* She was given a prosthesis, but quickly came to hate it. It was a standard myoelectric system, using a pair of...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for September 12, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
FDA OKs expanded trial for Precision Biopsy’s ClariCore prostate biopsy device
Precision Biopsy said today it won an investigational device exemption from the FDA to expand the trial of its ClariCore biopsy system, now looking to enroll prostate cancer patients in the newly...
View ArticleClik here to view.
Survey: The Fractured State of Enterprise Sales Enablement and Training
According to a recent Allego survey, 73% of salespeople in the medical/pharmaceutical industry believe insights from reps in the field would improve the sales enablement process at their company....
View ArticleClik here to view.
Orthofix launches study of pulsed electromagnetic fields in treating...
Orthofix (NSDQ:OFIX) said today it enrolled the 1st patient in a study exploring the use of its Physio-Stim pulsed electromagnetic field system for treating osteoarthritis of the knee. The Lewisville,...
View ArticleClik here to view.
Ethicon wins FDA nod for Enseal X1 tissue sealer
Johnson & Johnson (NYSE:JNJ) subsidiary Ethicon said today it won FDA 510(k) clearance for its Enseal X1 large jaw tissue sealer designed for vessel sealing and precise heat management. The...
View ArticleClik here to view.
Abbott touts 38% hypoglycemia reduction in FreeStyle Libre study
Abbott (NYSE:ABT) today released data from the Impact study of its FreeStyle Libre glucose monitor, touting significantly reduced hypoglycemia in type 1 diabetes patients. Data from the 328-patient...
View ArticleClik here to view.
ReWalk Robotics founder’s Upnride wheelchair lets you cruise through town...
(Reuters) — Israeli technology start-up Upnride Robotics is launching an innovative upright, self-stabilizing wheelchair at a medical conference in Germany next month and hopes to hit the market next...
View ArticleClik here to view.
Insulet launches artificial pancreas feasibility trial for Omnipod Horizon...
Insulet (NSDQ:PODD) said today that it’s launching a clinical trial of an artificial pancreas system based on its flagship Omnipod insulin management device for treating Type I diabetes. The Omnipod...
View ArticleClik here to view.
MDSAP authorities push for medical device industry participation
By Stewart Eisenhart, Emergo Group Officials overseeing the Medical Device Single Audit Program (MDSAP) developed to allow single quality system audits across multiple regulatory jurisdictions have...
View ArticleClik here to view.
FDA approves Medtronic’s In.Pact Admiral DCB for in-stent restenosis
Medtronic (NYSE:MDT) said today it won FDA premarket approval for its In.Pact Admiral drug-coated balloon with indications for treating in-stent restenosis in peripheral artery disease patients. The...
View ArticleClik here to view.
XL Precision Technologies operational in new U.S. facility
XL Precision Technologies Ltd. has recently announced the opening of a new facility in West Chester, PA. In response to the increasing business in the U.S., the facility will cater to the North...
View ArticleClik here to view.
Wearable generator that harvests heat could power devices
Researchers at North Carolina State University developed a wearable that can harvest body heat to power devices with at least 20 times the efficiency of other methods, the school reported yesterday....
View ArticleClik here to view.
Adhezion Biomedical, Pfizer ink long-term supply deal
Adhezion Biomedical announced today that it inked a long-term supply deal with Pfizer (NYSE:PFE) for exclusive U.S. distribution rights for Adhezion’s topical skin adhesives. The Wyomissing, Pa.-based...
View ArticleClik here to view.
Glooko, Diasend ink merger deal, raise $8m
Diabetes device developers Glooko and Diasend said today that they completed a merger, with the combined companies operating under the Glooko moniker. The newly merged firms said their platforms...
View ArticleClik here to view.
NuVasive promotes Hannon to COO, Miles to vice chairman | Personnel Moves,...
NuVasive promotes Hannon to COO, Miles to vice chairman NuVasive Inc. (NSDQ:NUVA) said today that it promoted Jason Hannon to be its new president & CEOO, replacing Patrick MIles, who ws named vice...
View ArticleClik here to view.
Ablative Solutions wins FDA nod for Phase II chemical denervation trial
Ablative Solutions said today that the FDA approved a Phase II trial of its chemical denervation system for hypertension under its investigational new drug application. The trial, called Target-BP I,...
View Article